Researchers have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia.
Dementia is a group of brain diseases that share similar symptoms, such as memory, language, orientation, and behavioral issues. Vascular dementia generally develops in the…
Approved by the FDA earlier this year, the Alzheimer’s therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide…
A prominent childhood memory is of my grandparents living with and then dying from dementia. As is universal with dementia, there was a double blow:…
A study led by the Cicely Saunders Institute at King’s College London has found that while critical care admissions for people with dementia are going…
A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a…
Neuroscience researchers at Wayne State University published a review article that confirms the usefulness of neurofilament light (NfL) blood levels to predict the likelihood and…
A new article published in RadioGraphics examines the use of monoclonal antibody therapies for treating Alzheimer’s disease and alerts physicians to be on the lookout…
A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either…
Annabelle Singer was a postdoctoral researcher at the Massachusetts Institute of Technology when she helped develop a light and sound therapeutic system that opened the…